Department of Neurology, RWTH University Hospital, Pauwelsstrasse 30, 52074 Aachen, Germany.
Proteomics Facility, IZKF, RWTH Aachen University, 52074 Aachen, Germany.
Biochem J. 2021 Jun 25;478(12):2179-2199. doi: 10.1042/BCJ20201000.
The regulation of proteasome activity is essential to cellular homeostasis and defects have been implicated in various disorders including Parkinson disease. The F-box protein FBXO7 has been implicated in early-onset parkinsonism and has previously been shown to have a regulatory role in proteasome activity and assembly. Here, we report the association of the E3 ubiquitin ligase FBXO7-SCF (SKP1, cullin-1, F-box protein) with the BAG6 complex, consisting of the subunits BAG6, GET4 and UBL4A. We identify the subunit GET4 as a direct interactor of FBXO7 and we show that the subunits GET4 and UBL4A are required for proper proteasome activity. Our findings demonstrate reduced binding of FBXO7 variants to GET4 and that FBXO7 variants bring about reduced proteasome activity. In addition, we find that GET4 is a non-proteolytic substrate of FBXO7, that binding of GET4 to BAG6 is enhanced in the presence of active FBXO7-SCF and that the cytoplasmic localization of the BAG6 complex is dependent on the E3 ubiquitin ligase activity. Taken together, our study shows that the parkinsonism-associated FBXO7 cooperates with the BAG6 complex in proteasome function and determines the subcellular localization of this complex.
蛋白酶体活性的调节对于细胞内稳态至关重要,缺陷与各种疾病有关,包括帕金森病。F-box 蛋白 FBXO7 与早发性帕金森病有关,先前已显示其在蛋白酶体活性和组装中具有调节作用。在这里,我们报告 E3 泛素连接酶 FBXO7-SCF(SKP1、cullin-1、F-box 蛋白)与 BAG6 复合物的关联,该复合物由 BAG6、GET4 和 UBL4A 亚基组成。我们确定亚基 GET4 是 FBXO7 的直接相互作用子,并且我们表明 GET4 和 UBL4A 亚基对于适当的蛋白酶体活性是必需的。我们的研究结果表明,FBXO7 变体与 GET4 的结合减少,并且 FBXO7 变体导致蛋白酶体活性降低。此外,我们发现 GET4 是 FBXO7 的非蛋白水解底物,在活性 FBXO7-SCF 的存在下,GET4 与 BAG6 的结合增强,并且 BAG6 复合物的细胞质定位依赖于 E3 泛素连接酶活性。总之,我们的研究表明,与帕金森病相关的 FBXO7 与 BAG6 复合物在蛋白酶体功能中协同作用,并决定该复合物的亚细胞定位。